Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8696 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8647 |
High Similarity |
NPD7473 |
Discontinued |
0.8521 |
High Similarity |
NPD7199 |
Phase 2 |
0.8488 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8434 |
Intermediate Similarity |
NPD37 |
Approved |
0.8421 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8393 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8393 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8383 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8294 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8286 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8229 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8225 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8177 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.814 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8107 |
Intermediate Similarity |
NPD1934 |
Approved |
0.809 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8057 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8057 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8057 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7953 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7919 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7889 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7889 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7849 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7836 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7833 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7802 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7797 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7772 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD919 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7633 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7545 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7449 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7449 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD3226 |
Approved |
0.74 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7399 |
Intermediate Similarity |
NPD920 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7398 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7398 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.738 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7353 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7349 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7321 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7294 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7291 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7289 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7283 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7267 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7178 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7158 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7157 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7126 |
Intermediate Similarity |
NPD943 |
Approved |
0.7118 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7105 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7077 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7076 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7065 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7037 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7018 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.6994 |
Remote Similarity |
NPD2800 |
Approved |
0.6989 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6971 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6961 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6961 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7584 |
Approved |
0.6941 |
Remote Similarity |
NPD6651 |
Approved |
0.694 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1608 |
Approved |
0.6923 |
Remote Similarity |
NPD1613 |
Approved |
0.6923
|
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |